When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BMY - Celgene teams up with Immatics in cancer immunotherapies
Bristol-Myers Squibb Company
Celgene (NASDAQ:CELG) inks an agreement with German outfit Immatics Biotechnologies GmbH for options to develop and commercialize three T cell receptor therapies, cancer treatments similar to CAR-Ts, but different in that they recognize targets inside cancer cells rather than on the surface.
More news on: Celgene Corporation, Bristol-Myers Squibb Company, Healthcare stocks news,